3/16
02:28 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
3/16
02:28 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
3/3
02:07 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
3/2
01:51 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
3/2
01:51 pm
kymr
Rating for KYMR
Low
Report
Rating for KYMR
3/2
09:21 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR
2/26
05:03 pm
kymr
Kymera Therapeutics (KYMR) had its "overweight" rating reaffirmed by Morgan Stanley.
Medium
Report
Kymera Therapeutics (KYMR) had its "overweight" rating reaffirmed by Morgan Stanley.
2/26
05:03 pm
kymr
Kymera Therapeutics (KYMR) had its "overweight" rating reaffirmed by Morgan Stanley.
Medium
Report
Kymera Therapeutics (KYMR) had its "overweight" rating reaffirmed by Morgan Stanley.
2/26
02:11 pm
kymr
Kymera Therapeutics (KYMR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Medium
Report
Kymera Therapeutics (KYMR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
2/26
02:11 pm
kymr
Kymera Therapeutics (KYMR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Medium
Report
Kymera Therapeutics (KYMR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
2/26
01:39 pm
kymr
Rating for KYMR
Medium
Report
Rating for KYMR
2/3
08:03 am
kymr
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $138.00 price target on the stock.
Low
Report
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $138.00 price target on the stock.
2/3
06:58 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR
1/28
10:00 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR
1/28
10:00 am
kymr
Rating for KYMR
Low
Report
Rating for KYMR